HighTower Advisors
LABU icon

HighTower Advisors’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

HighTower Advisors’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-400
Closed -$3.52K – 3571
2023
Q1 		$3.52K Buy
+400
New +$54.2K ﹤0.01% 3256

Other funds holding LABU

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
GTS Securities
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
Two Sigma Securities
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
McGuire Investment Group
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
CIBC Bancorp USA
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Allworth Financial
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
Ethos Financial Group
Ethos Financial Group King Of Prussia, Pennsylvania $1.5B AUM 22.75% 1-Year Est. Return

HighTower Advisors's LABU Position: Q2 2026 in Review

HighTower Advisors held its Direxion Daily S&P Biotech Bull 3X ETF (LABU) position steady in Q2 2026 at 1,400 shares worth $409K. The position accounts for ﹤0.01% of the portfolio, ranked #2930.

HighTower Advisors first reported a position in LABU in Q2 2020 and has held it in 7 quarters since. The position peaked at $559K in Q4 2025. 37 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

  • HighTower Advisors held 1,400 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $409K as of Q2 2026.
  • HighTower Advisors left its Direxion Daily S&P Biotech Bull 3X ETF share count unchanged in Q2 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #2930 holding.
  • HighTower Advisors first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2020 and has held it in 7 quarters since.
  • HighTower Advisors's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $559K in Q4 2025.
  • 37 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.